Guosheng Yin
Cited by
Cited by
Reinforcement learning in healthcare: A survey
C Yu, J Liu, S Nemati, G Yin
ACM Computing Surveys (CSUR) 55 (1), 1-36, 2021
Root canal filled versus non‐root canal filled teeth: a retrospective comparison of survival times
DJ Caplan, J Cai, G Yin, BA White
Journal of public health dentistry 65 (2), 90-96, 2005
ErbB2 increases vascular endothelial growth factor protein synthesis via activation of mammalian target of rapamycin/p70S6K leading to increased angiogenesis and spontaneous …
KS Klos, SL Wyszomierski, M Sun, M Tan, X Zhou, P Li, W Yang, G Yin, ...
Cancer research 66 (4), 2028-2037, 2006
Cure rate models: a unified approach
G Yin, JG Ibrahim
Canadian Journal of Statistics 33 (4), 559-570, 2005
Bayesian model averaging continual reassessment method in phase I clinical trials
G Yin, Y Yuan
Journal of the American Statistical Association 104 (487), 954-968, 2009
Bayesian dose-finding in phase I/II clinical trials using toxicity and efficacy odds ratios
G Yin, Y Li, Y Ji
Biometrics 62 (3), 777-787, 2006
Bayesian dose finding in oncology for drug combinations by copula regression
G Yin, Y Yuan
Journal of the Royal Statistical Society Series C: Applied Statistics 58 (2 …, 2009
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma
E Rivera, C Meyers, M Groves, V Valero, D Francis, B Arun, K Broglio, ...
Cancer 107 (6), 1348-1354, 2006
HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors
M Sun, C Behrens, L Feng, N Ozburn, X Tang, G Yin, R Komaki, ...
Clinical cancer research 15 (15), 4829-4837, 2009
Semiparametric transformation models for survival data with a cure fraction
D Zeng, G Yin, JG Ibrahim
Journal of the American Statistical Association 101 (474), 670-684, 2006
Clinical trial design: Bayesian and frequentist adaptive methods
G Yin
John Wiley & Sons, 2012
Nonparametric maximum likelihood approach to multiple change-point problems
C Zou, G Yin, L Feng, Z Wang
Bayesian quantile regression for longitudinal studies with nonignorable missing data
Y Yuan, G Yin
Biometrics 66 (1), 105-114, 2010
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung
P Yuan, H Kadara, C Behrens, X Tang, D Woods, LM Solis, J Huang, ...
PloS one 5 (2), e9112, 2010
Upregulation and activation of PKCα by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKCα and Src inhibitors
M Tan, P Li, M Sun, G Yin, D Yu
Oncogene 25 (23), 3286-3295, 2006
A latent contingency table approach to dose finding for combinations of two agents
G Yin, Y Yuan
Biometrics 65 (3), 866-875, 2009
Phase 3 study comparing the use of docetaxel on an every‐3‐week versus weekly schedule in the treatment of metastatic breast cancer
E Rivera, JA Mejia, BK Arun, RB Adinin, RS Walters, A Brewster, ...
Cancer 112 (7), 1455-1461, 2008
Bayesian dose finding by jointly modelling toxicity and efficacy as time-to-event outcomes
Y Yuan, G Yin
Journal of the Royal Statistical Society Series C: Applied Statistics 58 (5 …, 2009
Bayesian optimal interval design for dose finding in drug-combination trials
R Lin, G Yin
Statistical methods in medical research 26 (5), 2155-2167, 2017
Outlier detection for high-dimensional data
K Ro, C Zou, Z Wang, G Yin
Biometrika 102 (3), 589-599, 2015
The system can't perform the operation now. Try again later.
Articles 1–20